Ernexa Therapeutics (ERNAW) Shares Issued (2024)

Ernexa Therapeutics (ERNAW) has 15 years of Shares Issued data on file, last reported at $21000.0 in Q1 2026.

• Quarterly Shares Issued fell 99.53% year-over-year to $21000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $21000.0 (down 99.53% YoY) and the FY2025 annual result came in at $5000.0, down 97.14% from the prior year.
• Shares Issued climbed to $21000.0 in Q1 2026, from $5000.0 in the prior quarter.
• In the past five years, Shares Issued ranged from a high of $5.2 million in Q1 2022 to a low of $5000.0 in Q4 2025.
• A 5-year average of $1.4 million and a median of $510000.0 in 2023 frame the typical range for Shares Issued.
• Annual changes were most pronounced in 2024 — Shares Issued jumped 573.08% — and 2026, when it plunged 99.53%.
• Tracing ERNAW's Shares Issued over 5 years: stood at $359000.0 in 2022, then slumped by 92.76% to $26000.0 in 2023, then jumped by 573.08% to $175000.0 in 2024, then sank by 97.14% to $5000.0 in 2025, then soared by 320.0% to $21000.0 in 2026.
• The last three Shares Issued figures came in at $21000.0 (Q1 2026), $5000.0 (Q4 2025), and $305000.0 (Q3 2025), per Business Quant data.